Fenimore Asset Management Inc Pfizer Inc Transaction History

Fenimore Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$41.32 - $61.25 $10,330 - $15,312	-250 Reduced 2.35%	10,409 $615,000
Q4 2018 Jan 11, 2019	SELL	$38.47 - $43.86 $18,888 - $21,535	-491 Reduced 4.4%	10,659 $465,000
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $6,894 - $8,362	-200 Reduced 1.76%	11,150 $491,000
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $11,971 - $12,763	-363 Reduced 3.1%	11,350 $412,000
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $9,379 - $9,951	-282 Reduced 2.35%	11,713 $424,000
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $371,845 - $409,629	11,995	11,995 $428,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Fenimore Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Fenimore Asset Management Inc with notifications on news.